Radiofarmaseutikal
Radiofarmaseutikal spesifik > Teknesium-99m

Teknesium-99m adalah pemancar gamma. Ia diperoleh di lokasi di pusat pencitraan sebagai perteknetat terlarut yang dielusi dari generator teknesium-99m, dan kemudian digunakan secara langsung sebagai garam terlarut ini, atau digunakan untuk mensintesis sejumlah radiofarmasi berbasis teknesium-99m.
| Name | Investigation | Route of administration | In-vitro / in-vivo | Imaging / non-imaging |
| --- | --- | --- | --- | --- |
| Tc99m-pertechnetate | Thyroid uptake and thyroid imaging   Stomach and salivary gland imaging Meckel's diverticulum imaging Brain imaging Micturating cystogram First pass blood flow imaging First pass peripheral vascular imaging | IV | In-vivo | Imaging |
| Tc99m-pertechnetate | Lacrimal imaging | Eye drops | In-vivo | Imaging |
| Tc99m-Human albumin | Cardiac blood pool imaging | IV | In-vivo | Imaging |
| Tc99m-Human albumin | Peripheral vascular imaging | IV | In-vivo | Imaging |
| Tc99m-Human albumin macroaggregates or microspheres | Lung perfusion imaging | IV | In-vivo | Imaging |
| Tc99m-Human albumin macroaggregates or microspheres | Lung perfusion imaging with venography | IV | In-vivo | Imaging |
| Tc99m-Phosphonates and phosphates (MDP/HDP) | Bone imaging | IV | In-vivo | Imaging |
| Tc99m-Phosphonates and phosphates | Myocardial imaging | IV | In-vivo | Imaging |
| Tc99m-DTPA (diethylenetriaminepenta-acetic acid) | Renal imaging  First pass blood flow studies  Brain imaging | IV | In-vivo | Imaging |
| Tc99m-DTPA (diethylenetriaminepenta-acetic acid) | Lung ventilation imaging | Aerosol inhalation | In-vivo | Imaging |
| Tc99m-DMSA(V) (dimercaptosuccinic acid) | Tumor imaging | IV | In-vivo | Imaging |
| Tc99m-DMSA(III) (dimercaptosuccinic acid) | Renal imaging | IV | In-vivo | Imaging |
| Tc99m-Colloid | Bone marrow imaging   GI Bleeding | IV | In-vivo | Imaging |
| Tc99m-Colloid | Lymph node imaging | Interstitial | In-vivo | Imaging |
| Tc99m-Colloid | Esophageal transit and reflux imaging   Gastric emptying imaging | Oral | In-vivo | Imaging |
| Tc99m-Colloid | Lacrimal imaging | Eye drops | In-vivo | Imaging |
| Tc99m-HIDA (Hepatic iminodiacetic acid) | Functional biliary system imaging | IV | In-vivo | Imaging |
| Tc99m-Denatured (heat damaged) red blood cells | Red cell volume   Spleen imaging | IV | In-vitro | Non-imaging |
| Tc99m-Whole red blood cells | GI bleeding   Cardiac blood pool imaging Peripheral vascular imaging | IV | In-vivo | Imaging |
| Tc99m-MAG3 (mercaptoacetyltriglycine) | Renal imaging   First pass blood flow imaging | IV | In-vivo | Imaging |
| Tc99m-Exametazime (HMPAO) | Cerebral blood flow imaging | IV | In-vivo | Imaging |
| Tc99m-Exametazime labelled leucocytes | Infection/inflammation imaging | IV | In-vivo | Imaging |
| Tc99m-Sestamibi (MIBI - methoxy isobutyl isonitrile) | Parathyroid imaging   Non-specific tumor imaging Thyroid tumor imaging Breast imaging Myocardial imaging | IV | In-vivo | Imaging |
| Tc99m-Sulesomab (IMMU-MN3 murine Fab'-SH antigranulocyte monoclonal antibody fragments) | Infection/inflammation imaging | IV | In-vivo | Imaging |
| Tc99m-Technegas | Lung ventilation imaging | Inhalation | In-vivo | Imaging |
| Tc99m-Human immunoglobulin | Infection/inflammation imaging | IV | In-vivo | Imaging |
| Tc99m-Tetrofosmin | Parathyroid imaging   Myocardial imaging | IV | In-vivo | Imaging |
| Tc99m-ECD (ethyl cysteinate dimer) | Brain imaging----- | IV | In-vivo | Imaging |